KUNG38

CAS No. 1887033-00-2

KUNG38( KUNG-38 | KUNG 38 )

Catalog No. M12953 CAS No. 1887033-00-2

A potent, selective Grp94 inhibitor with Kd of 0.44 uM; displays 19-fold selecticity over Hsp90α.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1143 Get Quote
50MG 2322 Get Quote
100MG 3060 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    KUNG38
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective Grp94 inhibitor with Kd of 0.44 uM; displays 19-fold selecticity over Hsp90α.
  • Description
    A potent, selective Grp94 inhibitor with Kd of 0.44 uM; displays 19-fold selecticity over Hsp90α; induces the degradation of integrin α2 in MDA-MB-231 cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    KUNG-38 | KUNG 38
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    HSP
  • Recptor
    HSP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1887033-00-2
  • Formula Weight
    411.24
  • Molecular Formula
    C18H16Cl2N2O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ClC1=CC=C(CN2C=CN=C2CCC3=C(C(OC)=O)C(O)=CC(O)=C3Cl)O1
  • Chemical Name
    Methyl 3-Chloro-2-(2-(1-((5-chlorofuran-2-yl)methyl)-1H-imidazol-2-yl)ethyl)-4,6-dihydroxybenzoate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Crowley VM, et al. J Med Chem. 2016 Apr 14;59(7):3471-88.
molnova catalog
related products
  • PU-H71 HCl

    PU-H71 HCl (Zelavespib HCl) is a novel Hsp90 inhibitor, a novel purine-based analog, and a radiosensitizer that may be a promising agent for CIRT.

  • ITZ-1

    ITZ-1 is a client-selective Hsp90 inhibitor that efficiently induces heat shock factor 1 (HSF1) activation, selectively inhibits IL-1β-induced MMP-13 production (IC50=0.51 uM) via inhibition of ERK activation.

  • KNK-437

    An inhibitor of Heat shock protein (HSP) synthesis that dose-dependently inhibits the acquisition of thermotolerance and the induction of various HSPs including HSP105, HSP70, and HSP40 in human colon carcinoma cells.